PF-Atlas › Clinical Trials › NCT02354859
A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis
Gallium nitrate · Phase 2
Registry ID
NCT02354859
Phase
Phase 2
Status
Completed
Drug / intervention
Gallium nitrate
Sponsor
University of Washington
Start
2016-03
About this trial
Gallium nitrate is evaluated in NCT02354859, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University of Washington. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02354859 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.